Aims This study aimed to assess the impact of different antidiabetic agents on individuals
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …

Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …

SARS-CoV-2 infection has been a major threat to human health and a huge challenge to
Medicine. In only two years, COVID-19 affected> 350 million people, causing> 5.6 million …

Disorders of systemic metabolism can influence immunity. Individuals with obesity are
known to have increased inflammation, increased risk to select autoimmune diseases …

Lung adenocarcinoma (LUAD) is the most common and aggressive subtype of lung cancer,
and coronavirus disease 2019 (COVID-19) has become a serious public health threat …

Aim To investigate if patients with diabetes taking metformin have better outcomes versus
those not taking metformin following an emergency room visit for influenza. Methods Using …

Obesity is associated with impaired immune function, characterized by inflammation, and
leading to poor response to infection, impaired vaccine response, increased susceptibility to …

Background Diabetes, a chronic disease worldwide, may be associated with a poorer
prognosis in patients with coronavirus disease 2019 (COVID-19). While some …

Results Several overlapping mechanisms have been proposed to explain its antiviral
properties. It could bring about conformational changes in the angiotensin-converting …